July 21 Media Roundup
GSK is the first pharma to use Apple’s ResearchKit for clinical research (and we’re pretty excited to be a part of it).
Attracting and retaining patients has been a constant challenge in clinical trials. Companies are beginning to speak directly to patients to understand the challenges and concerns that keep them from joining a trial and are taking action to alleviate those burdens, such as offering car service to and from a trial site with Lyft.
Researchers look to mussels to heal tears inside the womb.
Sick of digital ads? Video art and digital screens are helping inspire wellness.
Diabetes therapies should be targeted at the gut.
A new study from Cedars-Sinai found that virtual reality may have a significant impact on how patients experience pain. After twenty minutes using VR software, pain was reduced by 24 percent on average. Researchers hope this new technology could curb patients’ dependence on opioids.
Machine learning takes on the workplace.
MIT and the Broad Institute find “mobile genes” shape culturally distinct microbiomes.
Our own Rouven Bergmann, Medidata’s chief financial officer, discusses vertical SaaS tech’s role play in advancing Joe Biden’s Cancer Moonshot plan.
“This is a reset, a reboot of what we thought about medicine,” says Eric Topol.
The Institute of Cancer Research and Breast Cancer Now rule out stress and trauma as causes of breast cancer.
Allen Institute researchers gather insight by studying mice watching movies.
Scientists convene to discuss CRISPR and gene editing ethics.
What causes immunotherapy resistance? Researchers at UCLA’s Jonsson Comprehensive Cancer Center look at tumor genomes.
Moving objects with your mind? “Modular prosthetic” tech rewires brains and bodies of amputees.
Simplified genetic test helps improve treatments and identify risk for ovarian cancer.
MIT’s Computer Science and Artificial Intelligence Laboratory is piloting an artificial intelligence scheduling system to streamline hospital procedures.